Skip to content

MidgardFinance.com

Home

Midgard Finance

Search for:

Recent Posts

Will regional banks survive and thrive after the 2023 banking crisis?
What happens next following FDA approval of Mounjaro® from Eli Lilly for diabetes?
Novo Nordisk 2021Q3 – Wegovy® bottlenecks
Novo Nordisk Q2 saw approval of Wegovy® and continued growth of Ozempic® sales
Novo Nordisk gains GLP-1 market share within and outside the US despite seeing new GLP-1 prescriptions curbed by COVID-19

Recent Comments

Anders Kristiansen on Novo Nordisk gains GLP-1 market share within and outside the US despite seeing new GLP-1 prescriptions curbed by COVID-19
tommycarstensen on Recent developments in the diabetes landscape halfway into 2019
Diabetes Doctor on Recent developments in the diabetes landscape halfway into 2019
tommycarstensen on Diabetes and the third quarter of 2019
tommycarstensen on Diabetes developments in the first quarter of 2019

Archives

May 2023
May 2022
November 2021
August 2021
October 2020
August 2020
July 2020
May 2020
March 2020
February 2020
January 2020
November 2019
October 2019
September 2019
August 2019
June 2019
May 2019
April 2019
February 2019
January 2019
November 2018
October 2018
September 2018

Categories

2019Q1
2019Q3
2019Q4
2023
Banks
Breweries
Consumer Goods
DataViz
Diabetes
Europe
Financial
FMCG
Healthcare
Pharmaceuticals
Quarterly Results
S&P500
Technology
Uncategorized

Meta

Log in
Entries feed
Comments feed
WordPress.org

Twitter feed is not available at the moment.

MidgardFinance.com, Proudly powered by WordPress.